|
CPSF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.482800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.565700E-02 |
| Normal-vs-Stage2 |
8.343800E-01 |
| Normal-vs-Stage3 |
7.209200E-01 |
| Normal-vs-Stage4 |
6.817800E-01 |
| Stage1-vs-Stage2 |
5.206600E-01 |
| Stage1-vs-Stage3 |
1.525440E-01 |
| Stage1-vs-Stage4 |
2.531800E-01 |
| Stage2-vs-Stage3 |
6.691600E-01 |
| Stage2-vs-Stage4 |
6.532600E-01 |
| Stage3-vs-Stage4 |
8.292400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.218000E-01 |
| Normal-vs-AfricanAmerican |
6.222600E-01 |
| Normal-vs-Asian |
5.000200E-01 |
| Caucasian-vs-AfricanAmerican |
9.308400E-01 |
| Caucasian-vs-Asian |
8.631800E-01 |
| AfricanAmerican-vs-Asian |
8.489800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.893600E-01 |
| Normal-vs-Female |
5.104600E-01 |
| Male-vs-Female |
1.991960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.269600E-01 |
| Normal-vs-Extreme_Weight |
3.988400E-02 |
| Normal-vs-Obese |
7.024800E-01 |
| Normal-vs-Extreme_Obese |
2.400100E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.255000E-01 |
| Normal_Weight-vs-Obese |
1.759960E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.785400E-01 |
| Extreme_Weight-vs-Obese |
3.422000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.338600E-01 |
| Obese-vs-Extreme_Obese |
1.117400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.047830E-01 |
| Normal-vs-Age(41-60Yrs) |
6.359600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.748400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.975200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.998040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.020500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.960500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.352380E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.715700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.079580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.668200E-01 |
| Normal-VS-Type2 PRCC |
2.804000E-03 |
| Normal-VS-KIRP CIMP |
2.044000E-01 |
| Normal-VS-Unclassified PRCC |
9.648200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.715400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.077780E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.101400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.979760E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.095900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.903770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.296380E-03 |
| Normal-vs-N1 |
3.360000E-02 |
| Normal-vs-N2 |
6.633500E-02 |
| N0-vs-N1 |
4.245100E-04 |
| N0-vs-N2 |
8.035400E-01 |
| N1-vs-N2 |
8.028400E-02 |
|
|
